CTOs on the Move

Psychiatric Medical Care

www.psychmc.com

 
Through the use of telepsychiatry technology, we’re able to help our partner facilities see patients more efficiently and in a wide variety of locations.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.psychmc.com
  • 4322, Harding Pike
    Nashville, TN USA 37205
  • Phone: 615.647.0750

Executives

Name Title Contact Details

Similar Companies

Nutrishare Inc

Nutrishare Inc is a Elk Grove, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Apicore, LLC

Apicore, LLC is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.

LucidHealth

Infrastructure, technology & strategic resources by radiologists, for radiologists.

ProMetic

ProMetic Life Sciences Inc. (www.prometic.com) is a long established biopharmaceutical company with globally recognized expertise in bioseparation, plasma-derived therapeutics and small-molecule drug development. ProMetic offers its state of the art technologies for large-scale purification of biologics, drug development, proteomics and the elimination of pathogens to a growing base of industry leaders and uses its own affinity technology that provides for highly efficient extraction and purification of therapeutic proteins from human plasma in order to develop best-in-class therapeutics and orphan drugs. ProMetic is also active in developing its own novel small-molecule therapeutic products targeting unmet medical needs in the field of fibrosis, anemia, neutropenia, cancer and autoimmune diseases/inflammation as well as certain nephropathies. Headquartered in Laval (Canada), ProMetic has R&D facilities in the UK, the U.S. and Canada, manufacturing facilities in the UK and commercial activities in the U.S., Europe, Russia, Australia and Asia.

Berg Pharma

Berg Pharma focuses research on understanding how alterations in metabolism relate to disease onset. The company has a deep pipeline of early-stage technologies in CNS diseases and metabolic diseases that complement its late-stage clinical trial activity in cancer and prevention of chemotoxicity. Armed with use of the Berg Interrogative Biology™ discovery platform that translates biological output into therapeutic candidates, Berg Pharma is well positioned for rapid commercialization of its intellectual capital.